STX-001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for STX-001, covering 2025-10-29 to 2025-10-29. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab [Phase 1, Phase 2]